HeartRhythm

JULY 9, 2024

Cardiac electrophysiologic and Cardiovascular involvement has long been important in the surveillance, care, and prognosis of patients with both BMD and DMD, and is the leading cause of mortality in patients with DMD.

Electrophysiology 40

Electrophysiology Heart Failure Cardiomyopathy 40

American College of Cardiology

APRIL 24, 2024

The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.

Atrial Fibrillation 59

Atrial Fibrillation Heart Failure Electrophysiology Ablation 59

Journal of Cardiovascular Electrophysiology

JANUARY 17, 2025

ABSTRACT Atrial flutter (AFL), defined as macro-re-entrant atrial tachycardia, is associated with debilitating symptoms, stroke, heart failure, and increased mortality. Atypical AFL is a heterogenous group of re-entrant atrial tachycardias that most commonly occur in patients with prior heart surgery or catheter ablation.

Atrial Flutter 40

Atrial Flutter Electrophysiology Ablation Tachycardia 40

HeartRhythm

SEPTEMBER 25, 2023

In heart failure with reduced ejection fraction and heart failure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological (..)

Preserved Ejection Fraction 40

Preserved Ejection Fraction Electrophysiology Heart Failure Document 40

Circulation

JANUARY 8, 2024

BACKGROUND:The relationship between heart failure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF. Circulation, Ahead of Print. The pathophysiological basis of AF in the context of HF is presumed to result from atrial remodeling.

Atrial Fibrillation 45

Atrial Fibrillation Heart Failure Electrophysiology Arrhythmia 45

HeartRhythm

SEPTEMBER 4, 2023

Myocardial calcium (Ca2+) signaling plays a crucial role in contractile function and membrane electrophysiology. An abnormal myocardial Ca2+ transient is linked to heart failure and ventricular arrhythmias.

Heart Failure 40

Heart Failure Arrhythmia Electrophysiology Cardiomyopathy 40

Journal of the American Heart Association

FEBRUARY 14, 2025

The overexpression of Cav1 reset the influence of vagotomy.ConclusionsWe found that LIPUS had a direct effect on regional antiinflammation and antifibrosis, improved cardiac autonomic function and heart failure, protected the Cx43 (connexin43) protein, and reduced the risk of malignant arrhythmia during ICM.

Ultrasound 45

Ultrasound Electrophysiology Cardiomyopathy Arrhythmia 45

Cardiology Update

JANUARY 2, 2024

Heart Failure 2024 Date: May 11-14, 2024 Location: Lisbon, Portugal and online Overview: The Heart Failure Congress stands as the premier global gathering encompassing the full spectrum of heart failure. Hashtag: #ESCPrev2024 5. Hashtag: #HeartFailure2024 6.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

HeartRhythm

APRIL 28, 2024

Left bundle branch (LBB) area pacing (LBBAP) has become a cardiac resynchronization therapy (CRT) modality in patients with heart failure (HF) and LBB block (LBBB). However, the electrophysiological differences between LBBP and LVSP and the methods to differentiate LBBP from LVSP in patients with HF and LBBB need investigations.

Heart Failure 40

Heart Failure Electrophysiology 40

American College of Cardiology

APRIL 24, 2024

Brian Olshansky and John Mandrola currently featured presents a conundrum within the fields of electrophysiology and geriatric cardiology. The CON portion of the PRO/CON debate between Drs.

Atrial Fibrillation 48

Atrial Fibrillation Heart Failure Electrophysiology Ablation 48

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

This study aimed to assess the electrophysiological characteristics of atrial fibrillation patients with dilated cardiomyopathy and compare the long-term clinical outcomes between patients undergoing catheter ablation and medical therapy.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

Circulation: Heart Failure

JANUARY 28, 2025

Circulation: Heart Failure, Ahead of Print. BACKGROUND:The therapeutic armamentarium for heart failure with preserved ejection fraction (HFpEF) remains notably constrained.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Obesity Diabetes 40

DAIC

JUNE 11, 2024

Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. “As

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

DAIC

JULY 31, 2024

This potential vascular market for this product family is measured in millions of procedures per year, including cardiac interventions such as structural heart procedures and electrophysiology procedures, peripheral vascular interventions including renal interventions, endovascular aortic repair, and carotid artery interventions.

Myocardial Infarction 99

Myocardial Infarction Technology Angina Pulmonary 99

Circulation: Arrhythmia and Electrophysiology

JUNE 15, 2021

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Heart Failure 40

Heart Failure Electrophysiology Arrhythmia Circulation 40

Journal of Cardiovascular Electrophysiology

APRIL 10, 2025

ABSTRACT Background Despite leadless pacemakers (LPMs) showing promise, real-world data comparing them to transvenous pacemakers (TV-VVI) are insufficient and often contradictory, especially in patients without major comorbidities like heart failure. Objectives Comparing LPMs with TV-VVIs in real-world patients without HF.

Pacemaker 40

Pacemaker Heart Failure Atrial Fibrillation Bradycardia 40

Circulation: Arrhythmia and Electrophysiology

OCTOBER 22, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Exercise 40

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). Both AF and HF, when co-exist in a patient, have serious treatment and prognostic implications.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

American College of Cardiology

APRIL 24, 2024

He also has New York Heart Association (NYHA) class II heart failure with reduced ejection fraction and left ventricular ejection fraction (LVEF) 40%. PT is an 82-year-old man who presents with persistent, mildly symptomatic atrial fibrillation (AF) of approximately 4-5 months' duration.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Ablation 40

DAIC

DECEMBER 27, 2023

The robotic technology represented an entirely novel way to address heart rhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

Journal of Cardiovascular Electrophysiology

NOVEMBER 7, 2024

Central illustration: In this study comparing left bundle branch area pacing (LBBAP) versus endocardial resynchronization (Endo-CRT), both strategies were associated with a similar incidence of the composite outcome of heart failure-related hospitalization and all-cause mortality.

Heart Failure 40

Heart Failure Hospital Outcomes Strokes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 15, 2023

Impact of preceding systolic heart failure on risk of pacemaker-induced cardiomyopathy Abstract Background Pacemaker-induced cardiomyopathy is a well described phenomenon in patients with preserved ejection fraction at the time of permanent pacemaker implant.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Pacemaker Cardiomyopathy 40

Circulation

APRIL 1, 2025

BACKGROUND:Gene mutations are responsible for a sizeable proportion of cases of heart failure. Circulation, Ahead of Print. However, the number of patients with any specific mutation is small.

Electrophysiology 49

Electrophysiology Heart Failure Cardiomyopathy Circulation 49

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). Secondary endpoints included all-cause mortality and heart failure (HF)-related hospitalizations. vs. 39.4%, p =0.036).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Heart failure (HF) with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are associated with high morbidity and mortality. Recently, sinus rhythm (SR) maintenance (SRM) after catheter ablation (CA) of AF (AFCA) in HFpEF has shown to reduce adverse events as compared to medical treatment.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

DAIC

DECEMBER 29, 2023

Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heart rhythm maintenance, though some can experience adverse effects and limited efficacy.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

HeartRhythm

SEPTEMBER 8, 2023

Atrial fibrillation (AF) stands as the most prevalent cardiovascular disease, posing significant risks of stroke, heart failure (HF), and other complications that contribute to morbidity and mortality.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Cardiovascular Disease 40

HeartRhythm

OCTOBER 18, 2023

In addition to these electrophysiological and reversible changes, which occur relatively early during AF, AF has been shown to be also associated with cardiac structural alterations including atrial dilatation and the development of heart failure (2).

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure 40

DAIC

MAY 21, 2024

Africa is the second most populous and fastest growing continent, and yet has a nearly non-existent infrastructure of electrophysiology (EP) labs to provide cardiac ablation therapy. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest. J Am Coll Cardiol EP.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

Journal of Cardiovascular Electrophysiology

FEBRUARY 13, 2024

Abstract Introduction Heart failure (HF) and atrial fibrillation (AF) frequently co-exist. Contemporary classification of HF categorizes it into HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction (HFmrEF), and HF with preserved ejection fraction (HFpEF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Hospital 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 19, 2025

The characterization of the cardiac autonomic nervous system has resulted in a new understanding and appreciation of neurocardiology, leading to potential novel neuromodulation therapies in clinical cardiology and cardiac electrophysiology. Patients with heart failure may be improved clinically by potentiating parasympathetic tone.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Angina Ablation 40

DAIC

JULY 30, 2024

On Thursday, Sept. Kenigsberg The New Horizon of Remote Monitoring: Amy Tucker | Niraj Varma | Janet K.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Heart failure–related admissions were higher in the RVAP group (22.6% BACKGROUND:Right ventricular apical pacing (RVAP) can produce left ventricle dysfunction. mm;P=0.04). versus 5.1%;P=0.03).CONCLUSIONS:Conduction

Heart Failure 40

Heart Failure Electrophysiology Arrhythmia Circulation 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 12, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:A growing number of patients with tetralogy of Fallot develop left ventricular systolic dysfunction and heart failure, in addition to right ventricular dysfunction.

Congenital Heart Disease 40

Congenital Heart Disease Outcomes Electrophysiology Congenital 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

Abstract Introduction Cardiac contractility modulation (CCM) is a medical device-based therapy delivering non-excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action.

Cardiac Function 40

Cardiac Function Electrophysiology Physiology Heart Failure 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy. However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation.

Arrhythmia 75

Arrhythmia Heart Failure Ablation Outcomes 75